Towards the development of potent therapy against the Hepatitis C virus (Record no. 77497)

000 -LEADER
fixed length control field 02098ngm a2200373 a 4500
001 - CONTROL NUMBER
control field HST2974_1_2
003 - CONTROL NUMBER IDENTIFIER
control field UkLoHST
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m c
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr|cna|||a||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field vz|czazum
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 111014s2011 enk|||||||||||s|||v|eng d
028 50 - PUBLISHER NUMBER
Publisher number 2974
Source Henry Stewart Talks
035 ## - SYSTEM CONTROL NUMBER
System control number (UkLoHST)2072
040 ## - CATALOGING SOURCE
Original cataloging agency UkLoHST
Language of cataloging eng
Transcribing agency UkLoHST
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Neyts, Johan,
Affiliation (Rega Institute for Medical Research, K.U.Leuven, Belgium)
Relator code spk
245 10 - TITLE STATEMENT
Title Towards the development of potent therapy against the Hepatitis C virus
Medium [electronic resource] /
Statement of responsibility, etc. Johan Neyts.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. London :
Name of publisher, distributor, etc. Henry Stewart Talks,
Date of publication, distribution, etc. 2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 streaming video file (50 min.) :
Other physical details color, sound).
490 1# - SERIES STATEMENT
Series statement Antivirals : latest developments and future progress,
International Standard Serial Number 2056-452X
500 ## - GENERAL NOTE
General note Animated audio-visual presentation with synchronized narration.
500 ## - GENERAL NOTE
General note Title from title frames.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Contents: The HCV genome and replication cycle -- Interferon development -- Ribavirin -- Antiviral and GTP depletion correlation -- Selective inhibitors of HCV replication -- The NS2 cysteine and the NS3 serine proteases -- Protease inhibitors -- The NS3 helicase as an antiviral target -- NS4A/NS3, NS4B and NS5A as antiviral targets -- The NS5B RNA dependent RNA polymerase -- Nucleoside and non-nucleoside HCV inhibitors -- Double and triple combination therapies -- Debio-025 -- Resistance to HCV inhibitors -- D320E peptide mutation effect -- Role of NS5A or NS5B in resistance -- Wild type and CypA knock down studies -- Cis-trans isomerase activity of cyclophilins.
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Access restricted to subscribers.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: World Wide Web.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antiviral agents.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Hepatitis C virus.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Hepatitis C
General subdivision Treatment.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antiviral Agents.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Hepacivirus.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Hepatitis C
General subdivision drug therapy.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Henry Stewart talks.
Name of part/section of a work Biomedical & life sciences collection.
-- Antivirals.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/2072/">https://hstalks.com/bs/2072/</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/p/613/">https://hstalks.com/bs/p/613/</a>
Materials specified Series

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571